Fact-checked by Grok 2 weeks ago

Anaplasma

Anaplasma is a of Gram-negative, obligate intracellular bacteria in the family Anaplasmataceae, order Rickettsiales, class , and phylum . These small, pleomorphic, non-motile cocci, measuring 0.3–0.4 µm, are aerobic and form characteristic morulae within the vacuoles of host cells such as erythrocytes and granulocytes; they cannot be cultured on cell-free media. Primarily transmitted by ticks, Anaplasma species infect a wide range of vertebrate hosts, including ruminants, , , , and humans, causing zoonotic and veterinary diseases known as anaplasmoses. The genus comprises eight recognized species: A. marginale (the type species), A. centrale, A. ovis, A. bovis, A. phagocytophilum, A. platys, A. capra, and A. odocoilei. Key species include A. marginale, which causes bovine anaplasmosis—a severe hemolytic disease in cattle transmitted by ticks such as Dermacentor and Rhipicephalus species—and A. phagocytophilum, responsible for human granulocytic anaplasmosis (HGA) and equine granulocytic anaplasmosis, primarily vectored by Ixodes ticks. Other species like A. platys infect canine platelets, leading to cyclic thrombocytopenia, while A. capra has been associated with human infections in regions like China. Anaplasma bacteria exhibit complex interactions with their vectors and hosts, colonizing midgut and cells to facilitate transmission. Infections often present with fever, lethargy, and in animals, and flu-like symptoms in humans, with potential complications such as and ; early treatment with tetracyclines is effective. Due to their global distribution and emerging zoonotic potential, Anaplasma species pose significant and economic concerns, particularly in industries, with ongoing research focusing on competence and development.

Taxonomy

Classification

The genus Anaplasma is classified within the family Anaplasmataceae, order Rickettsiales, class , and phylum (formerly known as Proteobacteria). This taxonomic placement reflects its position among intracellular in the class. Phylogenetically, Anaplasma species are closely related to and other members of the Anaplasmataceae family, as evidenced by molecular analyses of 16S rRNA and groESL genes, which demonstrate shared evolutionary ancestry and genetic similarities within the order Rickettsiales. These analyses highlight the genus's position as part of a monophyletic group of tick-borne pathogens. The genus Anaplasma is delineated by key characteristics, including being Gram-negative, obligate intracellular bacteria that replicate within membrane-bound vacuoles in host blood cells, and are primarily transmitted by vectors such as ticks. At the family level, Anaplasmataceae encompasses the genera Anaplasma, , Neorickettsia, and , with Anaplasma distinguished by its specific for erythrocytes or granulocytes in hosts. For instance, species like A. marginale and A. phagocytophilum exemplify this genus-level .

History

The genus Anaplasma traces its origins to the early , when Sir Arnold Theiler identified A. marginale as a novel during research conducted in from 1908 to 1909. Theiler described it in 1910 as intraerythrocytic bodies in cattle blood, distinguishing them from previously known parasites and naming the organism Anaplasma marginale for its marginal position within red blood cells; this marked the first recognition of a rickettsial in . Early observations in the and established A. marginale as the causative agent of bovine , a tick-transmitted disease leading to fever, , and high mortality in , though it was initially confused with due to the shared intraerythrocytic location of the pathogens. In 1932, a similar tick-borne fever was reported in sheep in , later attributed to what is now known as A. phagocytophilum, though the etiological agent remained unnamed at the time and was not formally linked to the genus until decades later. The 1990s brought significant milestones with the identification of human granulocytic ehrlichiosis (HGE), first recognized in 1994 as a emerging tick-borne illness affecting neutrophils, initially classified under Ehrlichia. A pivotal reclassification occurred in 2001, when molecular phylogenetic analyses, including 16S rRNA gene sequencing, redefined the genus Anaplasma within the family Anaplasmataceae, incorporating species previously under Ehrlichia such as the HGE agent, formally named A. phagocytophilum, and expanding the genus to include A. bovis and A. platys. This restructuring renamed HGE as human granulocytic anaplasmosis, reflecting the pathogen's true taxonomic position.

Biology

Morphology

Anaplasma species are , intracellular characterized as small, pleomorphic cocci or coccobacilli, typically measuring 0.2–1.0 μm in diameter, though sizes can range up to 2 μm in some forms. They are non- and lack flagella, adapting to an intracellular lifestyle without the need for motility. These exhibit two distinct morphotypes observed under electron microscopy: reticulate cells, which are larger and contain loosely arranged nucleoids and ribosomes, and dense-core cells, which are smaller with compact nucleoids, representing developmental stages within host cells. The ultrastructure of Anaplasma reveals a double-membrane envelope typical of Gram-negative bacteria, but uniquely lacking a peptidoglycan layer in the periplasmic space, which is often irregular due to a ruffled outer membrane. The cytoplasm is ribosome-rich, supporting active protein synthesis, and fine DNA strands are visible, with no lipopolysaccharide in the outer membrane. Within host cells, Anaplasma bacteria replicate in membrane-bound vacuoles, forming characteristic morulae—mulberry-like clusters of 10–40 organisms that can reach 1.5–6 μm in diameter. In stained preparations, Anaplasma are not readily visible with standard Gram staining due to the absence of but appear as basophilic inclusions in Giemsa- or Wright-stained smears, often purple or dark against the host background. Electron microscopy further highlights the ribosome-dense and lack of a , confirming their rickettsial nature. Species-specific variations in include the positioning of inclusions: A. marginale forms round to oval inclusions typically located at the margin of bovine erythrocytes, appearing as peripheral basophilic bodies 0.3–1.0 μm in size on Giemsa-stained smears. In contrast, A. phagocytophilum inclusions occupy cytoplasmic vacuoles in s, often aligning with or resembling altered neutrophil granules, visible as intracytoplasmic clusters in stained leukocyte preparations.

Life Cycle

Anaplasma species are obligate intracellular bacteria that replicate exclusively within membrane-bound vacuoles in host cells, undergoing a developmental cycle without sporulation or cyst formation. The infectious dense-cored cells, also known as elementary bodies, enter host cells through endocytosis and differentiate into larger reticulate bodies, which multiply by binary fission to form intracellular clusters called morulae. These reticulate bodies subsequently undergo asymmetric, sacrificial division to form new dense-cored cells resembling sporulation, which are released to initiate subsequent infections in neighboring cells. Host cell tropism varies by species, determining the site of replication within the vertebrate host. For instance, A. marginale primarily infects bovine erythrocytes, where reticulate forms divide by binary fission within vacuoles, leading to hemolytic anemia in cattle. In contrast, A. phagocytophilum targets granulocytes such as neutrophils in mammals, including humans and animals, replicating inside specialized vacuoles that avoid lysosomal fusion. Recent studies (as of 2025) have shown that in A. phagocytophilum, reticulate cell replication occurs synchronously from 4–18 hours post-infection, followed by asynchronous conversion to dense-cored cells via asymmetric division involving the MreB protein, advancing understanding of infection dynamics and transmission. A. platys, specific to canines, infects platelets, resulting in a cyclic infection pattern with morula formation every 1–2 weeks, corresponding to waves of thrombocytopenia. In the phase, Anaplasma undergoes transstadial transmission in , persisting through larval, nymphal, and stages without transovarial passage to eggs. multiply by binary fission in tick epithelial cells and salivary glands, similar to the host cycle but without pronounced morphological distinctions between forms; for A. phagocytophilum, this occurs in species, while A. marginale replicates in Rhipicephalus ticks such as R. microplus. Morulae, visible as basophilic inclusions in Giemsa-stained host cells, represent the replicative stage and are a diagnostic hallmark across species.

Genomics

Genome Structure

The genomes of Anaplasma species consist of a single circular with sizes ranging from 1.05 to 1.5 million base pairs (Mbp). For example, the of A. marginale strain St. Maries measures 1,197,687 , while that of A. phagocytophilum strain HZ is 1,471,282 . The varies between 37% and 50% across species, with A. marginale exhibiting approximately 49.8% and A. phagocytophilum around 41.6%. This compact architecture reflects the obligate intracellular lifestyle of these , featuring high coding densities typically exceeding 80%. Gene content in Anaplasma genomes includes approximately 900 to 1,300 protein- genes, with a substantial fraction—often 40-50%—comprising hypothetical proteins of unknown . For instance, the A. marginale St. Maries encodes 949 coding sequences, of which a significant portion are annotated as hypothetical. Similarly, A. phagocytophilum HZ has 1,327 predicted protein-coding genes, with over half classified as hypothetical or conserved hypothetical proteins. Metabolic capabilities are limited, supporting essential pathways such as but lacking genes for de novo biosynthesis of most , necessitating reliance on host-derived nutrients. In contrast, pathways for biosynthesis, including complete purine and pyrimidine routes, are present in like A. marginale. Prominent gene families include those encoding major surface proteins (MSPs), which facilitate antigenic variation. The MSP1 and MSP2 superfamilies are expanded in Anaplasma genomes; for example, A. marginale contains 9 MSP1 family members and 56 MSP2 superfamily members (including pseudogenes), while A. phagocytophilum features over 100 p44/MSP2 paralogs. Genes for the type IV secretion system (T4SS), essential for host cell entry, are conserved and organized in operons, with A. marginale encoding VirB and VirD4 components across two loci. Plasmids are uncommon in Anaplasma and, when present, are small and non-essential. Some A. marginale strains harbor plasmids of 5-10 kb, such as the 4.9 kb pAM36 in the strain, which may carry conjugation-related genes but are not universally required for viability. No plasmids have been identified in A. phagocytophilum genomes.

Sequencing and Comparative Analysis

The first complete genome of an Anaplasma was that of A. marginale strain St. Maries, sequenced in 2005, revealing a 1.2 Mbp circular dominated by outer (OMP) genes that contribute to antigenic variation and immune evasion. This milestone highlighted the bacterium's compact adapted to intracellular , with over 1,000 genes, including those encoding major surface proteins like MSP1 and MSP2. Subsequent sequencing efforts expanded to other species, including the complete genome of A. phagocytophilum strain HZ in 2006, approximately 1.4 Mbp in size, which provided insights into its broader host range and virulence factors. In the 2010s, draft assemblies were generated for A. ovis and A. bovis, facilitating initial comparative studies, while more recent projects in the 2020s include whole-genome sequences of Mexican A. marginale strains and a Chinese A. bovis isolate representing the smallest known Anaplasma genome at 1.05 Mbp. Draft genomes of A. capra strains, each approximately 1.07 Mbp in size, were published in 2023, revealing its compact structure with 862 protein-coding genes and limited metabolic pathways similar to other species. Comparative genomic analyses across Anaplasma underscore genome reduction as a hallmark of their intracellular lifestyle, with sizes ranging from 1.05 to 1.5 Mbp and reduced metabolic capabilities compared to free-living relatives. Shared features include the type IV secretion system (T4SS) essential for host cell invasion and repeat-containing genes involved in protein-protein interactions, conserved across species to support . Notably, A. phagocytophilum genomes exhibit a higher proportion of pseudogenes than A. marginale, reflecting greater evolutionary flux and potential for host adaptation. Genomic diversity within Anaplasma is driven by mechanisms such as recombination in the msp2/p44 families, enabling rapid antigenic variation to evade host immunity, as observed in multiple strains. Strain typing commonly relies on sequencing the 16S rRNA and groESL , which reveal intraspecies polymorphisms useful for epidemiological tracking. While genomes are available for most major Anaplasma species, complete sequences remain absent for A. odocoilei, and A. capra has only recently seen draft assemblies from emerging isolates.

Species

Major Species

Anaplasma marginale is the primary pathogen within the genus affecting cattle, where it resides obligately within erythrocytes, leading to severe hemolytic anemia in infected hosts. This species is distributed worldwide, particularly in tropical and subtropical regions, with high prevalence in cattle populations across Latin America, Africa, and parts of North America. Key distinguishing traits include its small genome of approximately 1.2 million base pairs and the expression of major surface proteins (MSPs) such as MSP1a and MSP2, which facilitate adhesion to host cells and antigenic variation for immune evasion. Transmission occurs primarily via ticks like Dermacentor and Rhipicephalus species, as well as mechanical vectors such as biting flies. Anaplasma phagocytophilum targets granulocytes, including s, in a broad range of s such as humans, ruminants, , , and like and deer. It is the causative agent of and tick-borne fever in animals, with infections often presenting as subclinical or mild febrile illnesses. This species exhibits a global distribution, with notable endemicity in the northeastern and upper , northern , and parts of , primarily transmitted by ticks. Distinguishing features include its ability to inhibit neutrophil antimicrobial functions and replicate within membrane-bound vacuoles, supported by a encoding type IV secretion systems for host cell manipulation. Anaplasma ovis primarily infects erythrocytes of small ruminants, including sheep and , resulting in a milder form of compared to bovine counterparts. It is endemic in tropical and subtropical areas, with significant prevalence in the , , , and parts of . is tick-borne, mainly by Rhipicephalus species, and the bacterium shows in genes like msp4, allowing for variation across regions. Unlike more virulent relatives, A. ovis often causes subclinical infections with low parasitemia levels. Anaplasma centrale, a less virulent closely related to A. marginale, infects erythrocytes but induces a less severe , making it valuable as an attenuated live to mitigate acute bovine anaplasmosis. It is utilized in programs in regions like , , and parts of , where it provides cross-protection against A. marginale without fully preventing . Key traits include reduced transmissibility by —requiring high tick densities for spread—and shared immunodominant antigens with A. marginale, such as certain MSPs, which contribute to its vaccine efficacy. Distribution is tied to endemic areas, though regulatory restrictions limit its use in places like the and due to potential risks. Anaplasma platys specifically targets platelets in , forming intracytoplasmic morulae and causing infectious cyclic characterized by periodic platelet count fluctuations. First described in 1978, it has a cosmopolitan distribution, with higher incidence in tropical and subtropical zones, transmitted predominantly by the brown dog tick . Distinguishing morphological features include basophilic inclusions within platelets, and molecularly, it possesses genes for platelet adhesion. Infections are often mild and self-limiting in healthy . Anaplasma bovis resides in monocytes and macrophages of ruminants, particularly and wild species like , and is considered an emerging with generally low pathogenicity leading to subclinical infections. It is prevalent in , , and parts of and , with recent detections extending to . Transmission involves ticks such as Haemaphysalis and Rhipicephalus genera, and genomic analyses reveal a compact similar to other Anaplasma , encoding effectors for intracellular survival. Compared to erythrocyte-infecting relatives, A. bovis is less studied, with ongoing research into its zoonotic potential. Anaplasma caudatum infects granulocytes in cervids such as , causing mild or subclinical infections. It is primarily found in and , transmitted by ticks like Ixodes persulcatus, and is distinguished by its host specificity and limited geographic range compared to other species.

Emerging and Candidatus Species

Emerging and Candidatus species of Anaplasma represent provisional taxa identified through molecular methods but not yet formally classified due to challenges in and . These entities highlight the expanding within the genus, often detected in novel hosts or vectors via amplification of genes like 16S rRNA. Their provisional status underscores the limitations of current taxonomic criteria for obligate intracellular bacteria, which require viable cultures for official naming. One prominent example is Candidatus Anaplasma odocoilei, first detected in (Odocoileus virginianus) in the United States during the using 16S rRNA gene sequencing. This granulocyte-tropic agent was identified in neutrophils of experimentally infected deer, eliciting antibody responses detectable by indirect fluorescent antibody testing, and phylogenetic analysis placed it within the Anaplasma genus, closely related to A. phagocytophilum. Proposed as a novel species, A. odocoilei, in 2013, its status reflects reliance on molecular detection without in vitro propagation. Similarly, Candidatus Anaplasma capra was proposed in 2015 following its detection in (Capra hircus) in , where it causes febrile illness in infected animals and has zoonotic potential in humans. Identification relied on sequencing of the and 16S rRNA genes from samples, revealing intraerythrocytic morulae and phylogenetic clustering distinct from established species. This tick-borne , primarily associated with Haemaphysalis ticks, was initially found in 31% of goats in northern via 16S rRNA . Other provisional candidates include novel Anaplasma strains detected in wildlife, such as those in , , and other ungulates, provisionally termed variants like "Ca. A. africanum" based on 16S rRNA and multi-locus sequencing from and samples. In , Candidatus Anaplasma amazonensis has been identified in ticks and hosts like cats via targeting 16S rRNA, marking its first molecular detection in the region and suggesting broader ecological roles in neotropical vectors. These detections often occur through screening of vectors and reservoirs, revealing genetic diversity without cultured isolates. Key challenges in characterizing these Candidatus species stem from the inability to culture Anaplasma , necessitating dependence on molecular tools like 16S rRNA , which has limitations in species-level resolution due to sequence similarities. This reliance hinders fulfillment of taxonomic requirements, such as depositing type strains, and raises concerns about potential undescribed species in global and populations. Recent from 2017 to 2022 has increasingly documented co-infections of multiple Anaplasma variants in ticks like Haemaphysalis longicornis and H. flava, suggesting ecological interactions that may drive emergence and complicate detection.

Pathogenesis

Infection Mechanisms

Anaplasma species, as obligate intracellular , initiate infection by entering host cells primarily through attachment mediated by surface adhesins, followed by internalization via a type IV secretion system (T4SS) that injects effector proteins to manipulate host processes. In A. phagocytophilum, the T4SS, encoded by the virB , secretes effectors such as AnkA, an repeat protein translocated into the host within minutes of bacterial contact. AnkA undergoes phosphorylation by the host Abl-1, which activates signaling pathways that facilitate bacterial uptake while inhibiting phagolysosome fusion, thereby preventing degradation in acidified compartments. This entry mechanism ensures the bacteria reside in a modified conducive to replication without immediate lysosomal targeting. Once internalized, Anaplasma modifies its pathogen-occupied () to promote survival by excluding lysosomal markers such as LAMP-1 and V-type H⁺-ATPase, recruiting components from recycling endosomes and early endosomes instead. The interacts with the host and avoids fusion with autophagosomes or NADPH oxidase-containing vesicles, reducing production that could harm the . For acquisition, Anaplasma lacks genes for of and instead scavenges host by upregulating () receptors via T4SS effectors, enabling membrane biogenesis for bacterial division within the expanding . Surface proteins like major surface protein 2 (), encoded in the , further aid in anchoring the to host membranes for . Immune evasion is achieved through antigenic variation and suppression of host responses, allowing persistent replication. In A. phagocytophilum, the bacterium employs over 100 MSP2/p44 pseudogene cassettes that undergo recombination to generate variant surface proteins, altering epitopes to escape antibody recognition during chronic infection. Replication culminates in bacterial release via host cell lysis, where densely packed morulae burst the POV and cell membrane, or potentially through direct cell-to-cell transfer to adjacent host cells. Released bacteria disseminate via the bloodstream to infect new cells, perpetuating the cycle without extracellular persistence.

Host Interactions

Anaplasma species interact with their hosts by modulating immune responses and inducing specific pathological changes, primarily through intracellular replication that damages host cells. This replication within host cells leads to direct and triggers immune-mediated clearance, contributing to across various species. In A. phagocytophilum, a key immune modulation strategy involves the inhibition of (ROS) production in neutrophils, despite stimulating NADPH assembly. The bacterium scavenges extracellular in a dose-dependent manner and resides in a that excludes essential oxidase components like gp91phox and p22phox, thereby evading oxidative killing. Additionally, A. phagocytophilum upregulates the pathway in infected neutrophils to promote anti-apoptotic , such as BCL2A1 and GADD45B, prolonging host cell survival and facilitating bacterial propagation. It induces production of such as IL-8, which promotes recruitment of additional neutrophils. Pathological effects vary by species tropism. In erythrocytic A. marginale, infection causes through extravascular destruction of both infected and uninfected erythrocytes by macrophages in the , liver, and , with peak parasitization reaching 10–65% of red blood cells during acute phases. For A. platys, which targets platelets in , thrombocytopenia arises initially from direct replication-induced injury to platelets forming morulae inclusions, followed by immune-mediated destruction of infected cells, resulting in cyclic platelet declines. Co-infections with Anaplasma species and other tick-borne pathogens such as Borrelia burgdorferi or Babesia microti are common in tick vectors and can occur in humans, with some animal studies suggesting potential for increased severity, though evidence in humans remains inconclusive. The host range of Anaplasma primarily encompasses ruminants, with domestic species like cattle, sheep, and goats serving as key reservoirs for A. marginale and A. phagocytophilum, while wildlife such as roe deer (up to 98.9% prevalence) and white-tailed deer act as maintenance hosts. Humans function as accidental dead-end hosts for A. phagocytophilum, experiencing granulocytic anaplasmosis without sustaining transmission cycles.

Transmission and Epidemiology

Vectors and Transmission

Anaplasma species are primarily transmitted by hard-bodied ticks of the family , which serve as biological vectors through a process involving bacterial replication within the tick. These ticks acquire the during blood meals on infected hosts and subsequently transmit them to new hosts via injection of infected during feeding. The transmission is transstadial, meaning the pathogen passes from one life stage of the tick to the next ( to to adult), but it is non-transovarial, with no passage from female ticks to their eggs. Specific tick vectors are associated with different Anaplasma species. For , the causative agent of , the primary vectors in are (blacklegged tick) and (western blacklegged tick), where nymphs and adult females are the main transmitting stages after acquiring infection as larvae. , responsible for bovine , is vectored mainly by species such as andersoni (Rocky Mountain wood tick) and (American dog tick) in the United States. For bovine pathogens including A. marginale, (Asian blue tick) acts as a key vector in tropical regions like and Africa. , which infects sheep and goats, is transmitted by ticks of the genus , along with species from , , and genera. , causing cyclic in dogs, is primarily vectored by (brown dog tick). , an emerging zoonotic species, is transmitted by ticks such as Haemaphysalis longicornis and Ixodes persulcatus. The primary mode of transmission occurs through the bite of an infected , where Anaplasma are released into the host via salivary secretions during feeding. Transmission can rarely occur through blood transfusions from infected donors, as documented in cases of A. phagocytophilum. Mechanical transmission by biting flies, such as horse flies () and stable flies (Stomoxys), is documented for some species like A. marginale, though it is not the primary mode for most Anaplasma species; contaminated needles or surgical instruments can also facilitate iatrogenic spread in veterinary settings. Vector competence involves bacterial multiplication initially in the tick's epithelial cells after acquisition, followed by dissemination to the salivary glands for . This process is temperature-dependent, with optimal replication and migration occurring between 32°C and 37°C, enabling efficient development during the tick's active feeding periods. In the vector's life cycle, larvae acquire Anaplasma from infected hosts, molt while maintaining the infection, and transmit as nymphs or adults.

Geographic Distribution

Anaplasma marginale, the causative agent of bovine anaplasmosis, is endemic in tropical and subtropical regions worldwide, spanning latitudes from approximately 40°N to 32°S, including parts of the , , , , and . In contrast, Anaplasma phagocytophilum, responsible for (HGA) and related diseases, predominates in temperate zones of , , and . These distributions reflect the bacterium's adaptation to specific ecological niches influenced by host availability and environmental conditions. Regional hotspots for A. phagocytophilum infections include the northeastern and upper , where HGA cases are most frequently reported, as well as areas in associated with high tick activity. In , prevalence is notable in regions with suitable habitats for transmission. Emerging concerns involve Anaplasma capra, a zoonotic species first identified in northeastern and now reported in multiple countries across (including Japan and Malaysia), , and Africa. Key reservoirs for A. phagocytophilum include small mammals such as , which maintain the pathogen in enzootic cycles. For A. marginale, and wild bovids serve as primary reservoirs, facilitating persistence in endemic areas. Climate-driven tick range expansions, including northward shifts in , are contributing to the broadening of these distributions. Incidence of has risen since 2000, attributed in part to effects on habitats, with global prevalence of A. phagocytophilum infections showing over a 41% increase over a 15-year period. In the United States, approximately 5,000 cases of HGA are reported annually, underscoring the growing impact.

Clinical Aspects

Diseases in Animals

Bovine anaplasmosis, caused by Anaplasma marginale, manifests as a hemolytic primarily affecting , with clinical signs including high fever (up to 42°C), progressive , , lethargy, , and abortion in pregnant animals. In severe cases, particularly in adult over two years old, mortality can reach 30-50% without prompt , while younger calves typically exhibit milder symptoms but still face risks of significant production losses. The disease imposes substantial economic burdens on and industries, with annual global losses estimated at $300-900 million due to mortality, reduced yield, decreased , and costs. Ovine and caprine anaplasmosis, induced by Anaplasma ovis and A. capra, presents milder symptoms compared to bovine forms, including fever, icterus (), pallor of mucous membranes, , and occasional or , though infections are often subclinical in small ruminants. A. capra, an emerging , primarily affects goats and sheep with typically mild or infections. Prevalence is notably high in regions like the and , where serological studies report rates of 13.5-89.7% in sheep and goats, driven by vectors and favorable environmental conditions for transmission. In dogs, Anaplasma platys causes infectious cyclic , characterized by recurring drops in platelet counts every 1-2 weeks, leading to potential tendencies such as petechiae, epistaxis, or , alongside fever, anorexia, and in symptomatic cases. However, many infections remain subclinical, with clinical disease being mild and self-limiting in naturally exposed animals, though severe often occurs in acute cases. Granulocytic anaplasmosis, primarily due to , affects equines and , causing fever, , limb , , and icterus in , often resolving with supportive care but posing risks in naive populations. In such as deer, infections lead to fever, rapid pulse, , and coordination loss, contributing to population declines in endemic areas. Emerging cases have been noted in settings, highlighting the pathogen's broadening host range beyond domestic species. Overall, Anaplasma infections in carry low direct zoonotic potential, though shared vectors like species facilitate indirect transmission risks to humans. In regions with high bovine prevalence, using the live attenuated Anaplasma centrale is employed to reduce clinical severity and economic impacts, particularly in and parts of . In 2024, researchers developed a genetically modified live that provides protection against A. marginale for at least one month in .

Diseases in Humans

Human granulocytic anaplasmosis (HGA), primarily caused by , is an acute febrile illness transmitted to humans via the bite of infected blacklegged ticks () or western blacklegged ticks (). Symptoms typically emerge 5–14 days after a tick bite and include fever, headache, malaise, myalgia, chills, and fatigue, often accompanied by laboratory abnormalities such as , , and elevated liver enzymes. These nonspecific manifestations can mimic other tick-borne diseases, leading to diagnostic challenges in endemic regions. Individuals at higher risk for severe HGA include the elderly and those who are immunocompromised, with co-infections such as () or () commonly occurring in overlapping endemic areas due to shared vectors. Animal reservoirs like and small mammals facilitate human exposure by maintaining the bacterium in natural cycles. Complications from HGA are uncommon but can involve , (ARDS), renal failure, or , particularly in untreated or vulnerable patients. The is less than 1% with prompt , though it rises significantly without , reaching up to 10% in severe cases. Infections with other Anaplasma species in humans are rare; A. capra has been associated with flu-like symptoms such as fever, , malaise, and , primarily in since 2015, while A. platys-like strains have been documented in isolated cases, such as in , and no confirmed human infections with A. marginale exist. The first human cases of HGA were identified during the , initially classified as human granulocytic ehrlichiosis, before taxonomic reclassification renamed the causative agent A. phagocytophilum and the disease HGA in 2001.

Diagnosis and Management

Diagnostic Methods

of Anaplasma infections primarily relies on techniques that detect the directly or indirectly through host immune responses. remains a foundational method, involving the examination of Giemsa-stained peripheral blood smears to identify intracytoplasmic morulae, which are clusters of within host cells such as neutrophils for A. phagocytophilum or erythrocytes for A. marginale. However, this approach has low sensitivity, ranging from 20% to 80%, particularly in (HGA), due to the transient and low-level bacteremia, making it more useful in acute phases with high parasitemia but insufficient for routine screening. Molecular methods, particularly polymerase chain reaction (PCR), offer higher sensitivity and specificity for detecting Anaplasma DNA in blood, tissue, or tick samples. Conventional and real-time PCR assays commonly target conserved genes such as the 16S rRNA, msp2 (major surface protein 2), or groESL, enabling species-specific identification and quantification of bacterial load during acute infection. Real-time PCR is preferred for its rapid turnaround and ability to distinguish Anaplasma from closely related pathogens like Ehrlichia, with detection limits as low as 1-10 genome copies per reaction in clinical specimens. Serological tests detect host antibodies against Anaplasma antigens and are valuable for confirming past or ongoing , especially in convalescent phases. The indirect immunofluorescence assay (IFA) is the reference standard, where a greater than 1:64 for IgG antibodies indicates active or recent , often requiring paired acute and convalescent sera to demonstrate a fourfold rise. Enzyme-linked immunosorbent assay (ELISA) serves as a sensitive screening tool for large-scale surveillance or veterinary applications, detecting IgM and IgG with good specificity but potential with other tick-borne diseases. Advanced techniques enhance diagnostic precision for epidemiological and research purposes. Whole-genome sequencing (WGS) allows for strain typing and phylogenetic analysis by comparing full genomic sequences, revealing among Anaplasma isolates from different hosts or regions. Culture-based isolation, though challenging due to the obligate intracellular nature of the , can be attempted in specialized cell lines such as HL-60 promyelocytic cells for A. phagocytophilum or cell lines like ISE6, but success rates are low and require 3 facilities. Diagnostic challenges include the seasonal nature of infections, peaking in spring and summer due to activity, which may delay testing outside endemic periods, and the need to differentiate Anaplasma from based on clinical presentation and cell (e.g., neutrophils vs. monocytes). Combining multiple methods, such as with , improves overall accuracy, as no single test achieves 100% across all infection stages.

Treatment and Prevention

The primary treatment for (HGA) is , administered at 100 mg orally twice daily for 10-14 days, which leads to rapid clinical improvement in most cases. For pregnant individuals or those with contraindications to tetracyclines, rifampin at 300 mg twice daily for 7-10 days serves as an effective alternative, with documented favorable maternal and fetal outcomes in limited reports. In , tetracyclines such as oxytetracycline are the first-line antibiotics for in ruminants, typically given as a single at 20 mg/kg body weight to reduce parasitemia and support recovery. Supportive care is crucial for severe cases, particularly in cattle with pronounced anemia, where intravenous fluids help maintain hydration and blood transfusions may partially restore red blood cell volume to prevent collapse. These measures, combined with antibiotics, improve survival rates in acutely ill animals by addressing hemolytic effects. Prevention strategies emphasize tick control to interrupt transmission. For humans, applying repellents containing to skin and treating clothing with reduces tick attachment and pathogen exposure in endemic areas. In livestock, acaricides such as -based products applied to animals or environmental sprays effectively lower tick populations on pastures. plays a key role in veterinary control, with live attenuated Anaplasma centrale providing partial cross-protection against A. marginale in , reducing clinical disease severity without preventing infection entirely. No licensed exists for human anaplasmosis, though experimental approaches targeting adhesins like Asp14 have shown promise in preclinical models for eliciting protective immunity. Public health efforts include raising awareness of symptoms and risks in tick-endemic regions to promote early seeking of care, alongside screening blood donors for recent tick exposure or symptoms to mitigate transfusion-transmitted cases, despite the lack of FDA-approved tests. Confirmed transfusion transmissions underscore the need for deferral protocols based on travel or exposure history. Challenges in management include emerging tetracycline resistance in veterinary Anaplasma strains, which can lead to persistent infections despite treatment and complicate control in herds. The absence of a further limits long-term prevention options.

References

  1. [1]
    Anaplasma phagocytophilum - VetBact
    Nov 21, 2024 · Anaplasma phagocytophilum, Seven species have been described within the genus Anaplasma, which is most closely related to the genus Ehrlichia.
  2. [2]
    The genus Anaplasma: drawing back the curtain on tick–pathogen ...
    One of the predominant tick-borne pathogens is Anaplasma, a genus of obligate intracellular bacteria within the order Rickettsiales.Missing: taxonomy | Show results with:taxonomy
  3. [3]
    Molecular identification and characterization of Anaplasma capra ...
    May 17, 2019 · Anaplasma genus comprises a group of Gram-negative obligate intracellular bacteria that inhabit diverse eukaryotic hosts. Seven classified ...
  4. [4]
    [PDF] Chapter 3.4.1. – Bovine anaplasmosis - fmd with viaa test incl.
    Anaplasmataceae as genus incertae sedis. The revised genus Anaplasma now contains Anaplasma marginale as the type species, A. phagocytophilum the agent of ...
  5. [5]
    Taxonomy browser Taxonomy Browser (Pseudomonadota) - NCBI
    Genbank common name: proteobacteria. NCBI BLAST name: proteobacteria. Rank: phylum. Genetic code: Translation table 11 (Bacterial, Archaeal and Plant ...
  6. [6]
    Sequence Analysis of the msp4 Gene of Anaplasma ... - ASM Journals
    The organisms in the order Rickettsiales were recently reclassified based on biological characteristics and genetic analyses of 16S rRNA, groESL, and gltA genes ...
  7. [7]
    Phylogenetic analysis of the erythrocytic Anaplasma species based ...
    Phylogenetic analysis of the erythrocytic Anaplasma species based on 16S rDNA and GroEL (HSP60) sequences of A. marginale, A. centrale, and A. ovis and the ...
  8. [8]
    Anaplasmataceae - an overview | ScienceDirect Topics
    Six species and five types of strains genetically related are currently assigned to the genus Anaplasma including Anaplasma marginale, A. centrale, A. bovis, A.
  9. [9]
    Molecular investigation and phylogeny of Anaplasmataceae species ...
    Jun 23, 2017 · The family Anaplasmataceae is a member of the order Rickettsiales; it includes the genera Anaplasma, Ehrlichia, Neorickettsia and Wolbachia.
  10. [10]
    Anaplasma phagocytophilum—a widespread multi-host pathogen ...
    However, it is still argued, whether the granulocytic Anaplasma should eventually be reclassified as distinct from the erythrocytic Anaplasma and returned ...
  11. [11]
  12. [12]
    The natural history of Anaplasma marginale - PubMed
    Feb 10, 2010 · Anaplasma marginale (Rickettsiales: Anaplasmataceae), described by Sir Arnold Theiler in 1910, is endemic worldwide in tropical and subtropical areas.
  13. [13]
    A review of bovine anaplasmosis (Anaplasma marginale) with ...
    Sir Arnold Theiler determined that the described organism was not Babesia and named it Anaplasma marginale for its distinctive location at the edge of the red ...
  14. [14]
    The natural history of Anaplasma phagocytophilum - ScienceDirect
    Tick-borne fever (TBF), which is caused by the prototype of A. phagocytophilum, was first described in 1932 in Scotland. A similar disease caused by a related ...
  15. [15]
    Experimental Ixodes ricinus-Sheep Cycle of Anaplasma ... - Frontiers
    Feb 5, 2020 · Tick-borne fever was first identified in sheep from Scotland in 1932 (5), and the discovery of the etiological disease agent followed in ...
  16. [16]
    Human Granulocytic Anaplasmosis—A Systematic Review of ... - MDPI
    Jul 15, 2022 · In 2001, this pathogen was renamed Anaplasma phagocytophilum (AP), the causative agent of human granulocytic anaplasmosis (HGA) [4]. AP is a ...
  17. [17]
    unification of some species of Ehrlichia with Anaplasma, Cowdria ...
    Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with ...
  18. [18]
    Anaplasma phagocytophilum | Johns Hopkins ABX Guide
    Mar 17, 2025 · Cause of tick-borne infection in humans. Human granulocytic anaplasmosis (HGA), before 2001, was known as human granulocytic ehrlichiosis (HGE).
  19. [19]
    Mechanisms of Obligatory Intracellular Infection with Anaplasma ...
    A. phagocytophilum is an obligatory intracellular bacterium that replicates inside mammalian granulocytes and the salivary gland and midgut cells of ticks.Missing: delineation criteria
  20. [20]
    Anaplasma - an overview | ScienceDirect Topics
    Anaplasma spp. are small, often pleomorphic or coccoid, gram-negative, nonmotile cells ranging from 0.3 to 0.4 μm in diameter.Missing: lacking | Show results with:lacking
  21. [21]
    Understanding Anaplasmataceae pathogenesis using “Omics ... - NIH
    Jul 2, 2014 · The reticulated forms multiply by binary fission and form morulae, and then turn into the dense cored cells before being released.
  22. [22]
    Silencing of genes involved in Anaplasma marginale-tick ...
    Jul 16, 2009 · marginale seen within colonies is the reticulated (vegetative) form (RF) that divides by binary fission and results in formation of large ...
  23. [23]
    Experimental infection and co-infection of dogs with Anaplasma ...
    Apr 8, 2010 · Canine cyclic thrombocytopenia is caused by Anaplasma platys, a Gram-negative, obligate intracellular bacterium that infects platelets [1]. The ...
  24. [24]
    Complete genome sequencing of Anaplasma marginale reveals that ...
    The genome has a high coding density (86%), typical of streamlined intracellular bacteria that have a minimal coding content for maintaining life in particular ...
  25. [25]
    Anaplasma phagocytophilum HZ, complete genome - Nucleotide - NCBI
    Below is a merged response summarizing the genome statistics for *Anaplasma phagocytophilum* str. HZ across all provided segments. To retain all detailed information in a dense and organized format, I will use tables in CSV format where applicable, followed by a narrative summary for additional context. The information is consolidated based on the recurring themes (e.g., size, GC content, number of genes, pseudogenes, hypothetical proteins, and useful URLs) while preserving specific details like gene counts, examples, and locus tags.
  26. [26]
    Comparative genomics of first available bovine Anaplasma ...
    Nov 17, 2014 · Using a whole genome capture approach, we have sequenced the first A. phagocytophilum genome isolated from a cow.
  27. [27]
    Complete genome sequencing of Anaplasma marginale reveals that ...
    Jan 18, 2005 · All enzymes necessary for fatty acid synthesis were found. Complete pathways for de novo purine and pyrimidine biosynthesis were detected.
  28. [28]
    Mechanisms of Obligatory Intracellular Infection with Anaplasma ...
    Jul 1, 2011 · A. phagocytophilum is an obligatory intracellular bacterium that replicates inside mammalian granulocytes and the salivary gland and midgut cells of ticks.<|control11|><|separator|>
  29. [29]
    Comparative Whole Genome Analysis of an Anaplasma ...
    May 21, 2022 · Rickettsia strains commonly harbor conjugation genes either on plasmids or within the bacterial genome and are transmitted horizontally between ...
  30. [30]
    Knockout of an outer membrane protein operon of Anaplasma ...
    Apr 11, 2014 · We used Roche/454 and Illumina high-throughput genome sequencing to determine: 1) the location of plasmid sequences within the A. marginale ...
  31. [31]
    Opening the black box of Anaplasma phagocytophilum diversity
    The A. phagocytophilum genome is a double-stranded chromosome from 1.47 to 1.48 Mb (only fully sequenced genomes were considered here) without any associated ...
  32. [32]
    The Anaplasma ovis genome reveals a high proportion of ...
    Jan 21, 2019 · The genome annotation finds 76 genes/proteins with a role in transport, a similar number to other Anaplasma species (Table 3). The sec ...
  33. [33]
    Genomic characters of Anaplasma bovis and genetic diversity in China
    Mar 5, 2024 · The genome had 36 tRNAs, one tmRNA and 42 pseudogenes ( Table 1 ). It showed that A. bovis possessed the smallest genome, second smallest GC ...
  34. [34]
    Whole‐Genome Sequencing of Mexican Strains of Anaplasma ...
    Apr 14, 2020 · marginale genomes reported in databases have a G+C content between 46 and 52%), contigs of four Mexican strains were differentiated from ...
  35. [35]
    Review Genetic diversity of Anaplasma bacteria: Twenty years later
    According to proposed classification, the genus Anaplasma comprised six species: A. bovis, A. centrale, A. marginale, A. ovis, A. phagocytophilum, and A. platys ...
  36. [36]
    Phylogenomics Reveals a Diverse Rickettsiales Type IV Secretion ...
    May 1, 2010 · While few syntenic regions are found across Rickettsiales genomes (63), a conserved P-T4SS is a particularly definitive feature of these ...
  37. [37]
    Diversity of Anaplasma phagocytophilum Strains, USA - PMC
    We analyzed the structure of the expression site encoding the immunoprotective protein MSP2/P44 from multiple Anaplasma phagocytophilum strains in the United ...Missing: groESL | Show results with:groESL
  38. [38]
    Comparative Whole Genome Analysis of an Anaplasma ... - MDPI
    Anaplasma phagocytophilum is a Gram-negative obligate intracellular tick-borne alphaproteobacteria (family Anaplasmatacea, order Rickettsiales) with a ...
  39. [39]
    Genomic Characteristics of Emerging Intraerythrocytic Anaplasma ...
    The genome of A. capra was the smallest among members of the genus Anaplasma. The genomes of the 2 A. capra strains contained comparable G+C content and numbers ...
  40. [40]
    Anaplasma Phagocytophilum - StatPearls - NCBI Bookshelf - NIH
    Anaplasma phagocytophilum is an obligate gram-negative, intracellular bacterium that causes an acute febrile illness known as anaplasmosis or human granulocytic
  41. [41]
    A review on the eco-epidemiology and clinical management of ...
    Dec 21, 2019 · Anaplasma phagocytophilum, the agent of granulocytic anaplasmosis, from a human perspective, is considered one of the most important species as ...
  42. [42]
    Epidemiology and genetic diversity of Anaplasma ovis in goats in ...
    Jan 3, 2019 · Anaplasma ovis is a major cause of small ruminant anaplasmosis, a tick-borne disease mainly affecting small ruminants in tropical and ...
  43. [43]
    Characterization of Anaplasma marginale subsp. centrale Strains by ...
    Anaplasma marginale subspecies centrale also infects cattle; however, it causes a milder form of anaplasmosis and is used as a live vaccine against A. marginale ...
  44. [44]
    Anaplasma platys - an overview | ScienceDirect Topics
    Anaplasma platys is an intracellular bacterium transmitted by ticks, infecting platelets in dogs, causing infectious cyclic thrombocytopenia. It is an ...
  45. [45]
    Detection of Anaplasma bovis-like agent in the Southcentral United ...
    Anaplasma bovis is primarily an infectious agent of ruminants, and has most commonly been reported in Asia, the Middle East, and Africa.
  46. [46]
    Unravelling the diversity of Anaplasma species circulating in ...
    Anaplasma ST KNP-1 was detected primarily in impala, but was also identified in buffalo, kudu, zebra, leopard, lion and African elephant samples. Anaplasma ST ...
  47. [47]
    Anaplasma odocoilei sp. nov. (family Anaplasmataceae) from white ...
    Five of 6 deer developed antibodies reactive to Anaplasma sp. antigen, as detected by indirect fluorescent antibody testing. Phylogenetic analyses of 16S rRNA, ...
  48. [48]
    Detection and Phylogenetic Characterization of Anaplasma capra
    Anaplasma capra was initially identified in 37 (31%) of 120 blood samples from asymptomatic goats in northern China in 2012, based on both the 16S rRNA gene ( ...
  49. [49]
    Anaplasma Species in Africa—A Century of Discovery
    May 12, 2023 · The Anaplasma genus was discovered over a century ago in 1910 by Sir Arnold Theiler in South Africa [1,2]. Anaplasma spp. are the causative ...Missing: authoritative | Show results with:authoritative
  50. [50]
    Molecular Detection of Tick-Borne Agents in Cats from Southeastern ...
    The present study showed, for the first time, the occurrence of 'Candidatus Anaplasma amazonensis' in cats and the first molecular detection of Anaplasma sp.
  51. [51]
    The Use and Limitations of the 16S rRNA Sequence for Species ...
    We examined the utility of the 16S rRNA gene sequence for discriminating Anaplasma samples to the species level.<|control11|><|separator|>
  52. [52]
    Co-existence of Multiple Anaplasma Species and Variants in Ticks ...
    Jun 9, 2022 · Anaplasma spp. are causative agents of anaplasmosis, with a significant impact on the health of a number of animals and human species, as well ...
  53. [53]
  54. [54]
    The Pathogen-Occupied Vacuoles of Anaplasma phagocytophilum ...
    Feb 29, 2016 · Here, we demonstrate that the ApV and AmV extensively interact with the host endoplasmic reticulum (ER) in endothelial, myeloid, and/or tick cells.Missing: vacoule evasion
  55. [55]
    Anaplasmosis in Ruminants - Circulatory System
    Anaplasmosis traditionally refers to a disease of ruminants caused by obligate intraerythrocytic bacteria of the order Rickettsiales, family Anaplasmataceae, ...
  56. [56]
    Anaplasma phagocytophilum Utilizes Multiple Host Evasion ... - NIH
    As such, studies have demonstrated that neutrophils exhibit diminished production of reactive oxygen species (ROS) following A. phagocytophilum infection ...
  57. [57]
    Anaplasma phagocytophilum causes global induction of antiapoptosis in human neutrophils
    ### Summary of NF-κB in Anaplasma phagocytophilum Infection
  58. [58]
    First case of Anaplasma platys infection in a dog from Croatia
    Mar 9, 2012 · In dogs A. platys organisms infect peripheral blood platelets and form basophilic inclusions in the cells, so-called morulae, which contain one ...
  59. [59]
    Human Co-Infections between Borrelia burgdorferi s.l. and Other ...
    In a pioneer study, an increased severity (number of symptoms) and duration of illness were reported in patients co-infected with Lyme disease and babesiosis, ...<|separator|>
  60. [60]
    Co-Infection of Blacklegged Ticks with Babesia microti and Borrelia ...
    We find significant deviations of levels of co-infection in questing nymphs, most notably 83% more co-infection with Babesia microti and Borrelia burgdorferi ...
  61. [61]
    Anaplasma phagocytophilum—a widespread multi-host pathogen ...
    During an experimental study on louping-ill (LI) in Scotland last century, some sheep contracted an unknown fever reaction on tick-infested pastures. The fever ...
  62. [62]
    Hard Ticks as Vectors: The Emerging Threat of Tick-Borne Diseases ...
    Hard ticks (Ixodidae) play a critical role in transmitting various tick-borne diseases (TBDs), posing significant global threats to human and animal health.
  63. [63]
    Tick-Pathogen Interactions and Vector Competence - NIH
    Ticks and the pathogens they transmit constitute a growing burden for human and animal health worldwide. Vector competence is a component of vectorial capacity ...Tick Cytoskeleton · Tick Innate Immune Response · Tick-Microbiome Interactions
  64. [64]
    Transmission of Anaplasma phagocytophilum to Ixodes ricinus Ticks ...
    A. phagocytophilum is transstadially transmitted by these vector ticks, and there is no evidence of transovarial transmission (22, 27, 29, 37). Most studies to ...Missing: non- | Show results with:non-
  65. [65]
    Transmission of Anaplasma marginale Theiler by Dermacentor ...
    Transstadial transmission of A marginale occurred from cattle with parasitemias ranging from undetectable (in a carrier cow) to a peak of 27% (in an acutely ...
  66. [66]
    Molecular prevalence and associated risk factors of Anaplasma ovis ...
    We are reporting a moderate prevalence of Anaplasma ovis prevalence in Pakistani sheep and this data will help in developing the integrated control policies.
  67. [67]
    Pathogen transmission in relation to duration of attachment by ... - NIH
    The blacklegged tick, Ixodes scapularis, is the primary vector to humans in the eastern United States of a suite of seven pathogenic microorganisms: the deer ...Missing: non- | Show results with:non-
  68. [68]
    Transmission and Epidemiology | Anaplasmosis - CDC
    Jul 19, 2024 · Anaplasmosis, a tickborne disease, spreads through tick bites or rarely through blood transfusion.
  69. [69]
    Anaplasmosis in Ruminants - Circulatory System
    Dec 30, 2019 · Anaplasmosis is characterized by progressive anemia due to extravascular destruction of infected and uninfected erythrocytes. The prepatent ...
  70. [70]
    The replication rate of Anaplasma marginale is temperature ...
    Apr 22, 2025 · From 22-37°C replication in the salivary glands and/or movement of A. marginale from the midgut to salivary glands increases significantly, ...Missing: multiplication gut
  71. [71]
    About Anaplasmosis - CDC
    Sep 4, 2024 · Anaplasmosis is most commonly reported in the Northeastern and upper Midwestern states.
  72. [72]
    A novel genotype of “Anaplasma capra” in wildlife and its ...
    Dec 12, 2018 · Although “A. capra” has not yet been formally recognized, human cases of “A. capra” infection have been recorded in northeastern China, and ...
  73. [73]
    Reservoir Competence of Vertebrate Hosts for Anaplasma ...
    Fourteen vertebrate species (10 mammals and 4 birds) were assessed for their ability to transmit Anaplasma phagocytophilum, the bacterium that causes human ...
  74. [74]
    Climate change impacts on ticks and tick-borne infections | Biologia
    Nov 23, 2021 · Evidence climate change is impacting ticks and tick-borne infections is generally lacking. This is primarily because, in most parts of the world, there are no ...
  75. [75]
    Global status of Anaplasma phagocytophilum infections in human ...
    A total of 7018 cases of A. phagocytophilum were reported from 48,619 individuals examined across 22 countries in three continents. Overall pooled estimate was ...
  76. [76]
    Epidemiology and Statistics | Anaplasmosis - CDC
    Mar 3, 2025 · Average annual incidence of reported anaplasmosis by age group, United States 2018-2022. Average annual incidence of reported anaplasmosis by ...Missing: HGA | Show results with:HGA
  77. [77]
    Prevalence and risk factors for Anaplasma marginale seropositivity ...
    May 10, 2024 · Clinical signs of bovine anaplasmosis include fever, weight loss, lethargy, jaundice, abortion and death. The severity of the disease increases ...Missing: impact | Show results with:impact
  78. [78]
    Anaplasmosis in cattle - Texas A&M Veterinary Medical Diagnostic ...
    Death losses in such herds can approach 50%. Mature cattle are the most susceptible to severe clinical signs of the disease while cattle under six months of age ...Missing: untreated | Show results with:untreated
  79. [79]
    Keep a watchful eye out for anaplasmosis in cattle herds
    Jul 6, 2016 · Data indicate that 30 percent to 50 percent of infected cattle more than three years of age will die without early treatment.” It is important ...Missing: untreated | Show results with:untreated<|control11|><|separator|>
  80. [80]
    Using rumination and activity data for early detection of ...
    Bovine anaplasmosis causes considerable economic losses in dairy cattle production systems worldwide, ranging from $300 million to $900 million annually.Research · Results · Discussion
  81. [81]
    Economic Benefits of Diagnostic Testing in Livestock: Anaplasmosis ...
    Aug 2, 2021 · Of this, death loss contributes to the majority of anaplasmosis economic losses at 66%, followed by 16% from treatment, 11% from chronic cases, ...
  82. [82]
    Clinical signs, prevalence, and hematobiochemical profiles ... - NIH
    Anaplasma-infected sheep displayed the following clinical signs: Paleness of the mucous membrane, bloody diarrhea, emaciation, pyrexia, jaundice, nasal ...
  83. [83]
    Retrospective study of anaplasmosis in countries of North Africa and ...
    The serological assay results showed a prevalence of 13.5%-89.7% in cattle in North Africa, and 35%-36% in cattle, 44.7%-94% in small ruminants and 10.83% in ...Missing: Mediterranean | Show results with:Mediterranean
  84. [84]
    Diagnostic tools of caprine and ovine anaplasmosis: a direct ...
    May 22, 2018 · Anaplasma ovis was detected in 25.3% (25.9% of sheep and 24.4% of goats) of the sampled animals, while Anaplasma phagocytophilum was detected in ...
  85. [85]
    Anaplasmosis in Dogs - Infectious Diseases
    In cases of cyclic thrombocytopenia, the platelet counts wax and wane with a cycle of 1–2 weeks in the absence of treatment. Review of blood smears can reveal ...
  86. [86]
    Epidemiology, Diagnosis, and Control of Canine Infectious Cyclic ...
    Anaplasma platys was first detected in a dog from Florida and frequently infects platelets. ... The life cycle of all Anaplasma species hasnot yet been ...
  87. [87]
    An update on anaplasmosis in dogs - DVM360
    ... Anaplasma, Cowdria, Wolbachia, and Neorickettsia. In 2001, a major restructuring of the classification of organisms occurred in the order Rickettsiales.1 As ...
  88. [88]
  89. [89]
    Anaplasmosis | Game Commission | Commonwealth of Pennsylvania
    The most important mode of transmission for anaplasmosis is through the bite of a tick carrying the bacteria. Biting flies can also transmit the bacteria, but ...Missing: mechanical | Show results with:mechanical
  90. [90]
    Differential identification of Anaplasma in cattle and potential of ...
    Zoonotic potential has been shown for A. phagocytophilum, the agent of human granulocytic anaplasmosis, and for some other Anaplasma spp. that suggests a ...
  91. [91]
    Immunization with Anaplasma centrale Msp2 HVRs Is Less Effective ...
    Sep 29, 2023 · Anaplasma centrale does not prevent infection with A. marginale but does prevent acute disease. Anaplasma centrale is prohibited from being used ...
  92. [92]
    Anaplasmosis in the Amazon: diagnostic challenges, persistence ...
    This review focuses on Anaplasma marginale and Anaplasma phagocytophilum, the primary species associated with bovine and granulocytic anaplasmosis, respectively ...
  93. [93]
    Clinical Signs and Symptoms of Anaplasmosis - CDC
    May 15, 2024 · Common symptoms of anaplasmosis are fever, headache, and malaise. · Symptoms typically begin within 5-14 days after an infected tick bite; ...
  94. [94]
    The epidemiology and clinical manifestations of anaplasmosis in ...
    This systematic review and analysis aimed to synthesise the epidemiology, clinical features, diagnostic methods, and treatment outcomes of anaplasmosis.
  95. [95]
    [PDF] Human Granulocytic Anaplasmosis and Anaplasma phagocytophilum
    Human granulocytic anaplasmosis is a tickborne rick- ettsial infection of neutrophils caused by Anaplasma phagocytophilum. The human disease was first ...
  96. [96]
    Human Granulocytic Anaplasmosis and Anaplasma phagocytophilum
    Human granulocytic anaplasmosis is a tickborne rickettsial infection of neutrophils caused by Anaplasma phagocytophilum. The human disease was first identified ...
  97. [97]
    [PDF] Ehrlichiosis and Anaplasmosis in Mammals
    Each species of Anaplasma or Ehrlichia tends to infect certain blood cells or cell fragments (platelets), which can help distinguish these organisms in blood ...<|control11|><|separator|>
  98. [98]
    Human Granulocytic Anaplasmosis and Anaplasma phagocytophilum
    Human granulocytic anaplasmosis is a tickborne rickettsial infection of neutrophils caused by Anaplasma phagocytophilum. The human disease was first identified ...<|control11|><|separator|>
  99. [99]
    Use of Routine Complete Blood Count Results to Rule Out ... - NIH
    The sensitivity of peripheral blood smear examination for the detection of anaplasmosis ranges from 20% to 80%, and performance of this procedure is labor ...
  100. [100]
    Comparison of PCR Assays for Detection of the Agent of Human ...
    The specificity and limit of detection of the MSP2 and 16S rRNA direct assays were further tested by use of A. phagocytophilum template DNA from both North ...
  101. [101]
    Comparison of a Real-Time PCR Method with Serology and Blood ...
    Blood smear analysis also has poor sensitivity due to the transient nature of bacteremia, and it provides only supportive evidence of infection because of the ...
  102. [102]
    Clinical Testing and Diagnosis for Anaplasmosis - CDC
    May 15, 2024 · Antibody titers determined using immunoglobulin G (IgG) IFA tests are frequently negative (titer of less than 1:64) in the first week of illness ...Missing: immunofluorescence | Show results with:immunofluorescence
  103. [103]
    Anaplasma – PCR and Serology | Public Health Ontario
    Jul 2, 2025 · Serology testing is via a commercial indirect immunofluorescence assay (IFA) kit. ... Single serum titres ≥ 1:64 may suggest either an ...
  104. [104]
    Protein and DNA Biosynthesis Demonstrated in Host Cell-Free ...
    We investigated the use of an axenic medium for growth of two important pathogens—Anaplasma phagocytophilum and Ehrlichia chaffeensis—in host cell-free ...
  105. [105]
    Anaplasmosis Information for Health Professionals
    Sep 2, 2025 · Diagnostic tests · Polymerase chain reaction (PCR) assays are recommended, particularly for acute cases, to detect bacterial DNA and distinguish ...Clinical presentation · Diagnostic tests
  106. [106]
    Value of PCR, Serology, and Blood Smears for Human Granulocytic ...
    Mar 26, 2019 · For anaplasmosis, PCR testing appears to be the most effective diagnostic tool. However, the sensitivity of PCR is <100%, and combining PCR with ...Missing: 20-50% | Show results with:20-50%
  107. [107]
    Clinical Care of Anaplasmosis - CDC
    Jan 30, 2025 · Patients with suspected anaplasmosis should be treated with doxycycline for 10–14 days to provide appropriate length of therapy for possible ...Missing: granulocytic | Show results with:granulocytic
  108. [108]
    Diagnosis and Management of Tickborne Rickettsial Diseases ...
    May 13, 2016 · The reported case-fatality rate during 2008–2012 was 0.3% and was higher among persons aged ≥70 years and those with immunosuppression (3). I.
  109. [109]
    Anaplasmosis | The Cattle Site
    Tetracycline is often used for clinical anaplasmosis. However it cannot be used in every country. General supportive care is also important for anemic animals.
  110. [110]
    Personal protection measures to prevent tick bites in the United States
    This includes using repellents, wearing untreated or permethrin-treated protective clothing, and conducting tick checks after coming inside.
  111. [111]
    Rodent-targeted approaches to reduce acarological risk of human ...
    In this review, I first outline general benefits and drawbacks of rodent-targeted tick and pathogen control methods, and then describe the empirical evidence.
  112. [112]
    Immunization against Anaplasma phagocytophilum Adhesin Binding ...
    Sep 18, 2020 · No granulocytic anaplasmosis vaccine exists. Because A. phagocytophilum is an obligate intracellular bacterium, inhibiting microbe-host cell ...
  113. [113]
    Ehrlichiosis and Anaplasmosis among Transfusion and Transplant ...
    PCR testing would more accurately screen contaminated blood and organ products, but no FDA-licensed test is available. Donor deferral on the basis of travel or ...
  114. [114]
    <I>Anaplasma phagocytophilum</I> Transmitted Through Blood ...
    Oct 24, 2008 · This is the first published report in which transfusion transmission of A. phagocytophilum was confirmed by testing of the recipient and a donor.
  115. [115]
    Failure to Eliminate Persistent Anaplasma marginale Infection ... - NIH
    Nov 20, 2021 · Oxytetracycline (OTC) and chlortetracycline (CTC) are indicated for treatment [17] and control [18] of anaplasmosis, respectively. Currently, ...
  116. [116]
    VirB10 vaccination for protection against Anaplasma phagocytophilum
    Dec 18, 2018 · Currently there are no vaccines available against HGA. Conserved membrane proteins that are subdominant in Anaplasma species, such as VirB9 and ...Virb10 Induces Cd4 Th1... · Discussion · Methods